RealFeedApp Investments in neuroscience startups reached $1.9 billion
From 2023 to 2025, startups focused on the central nervous system raised $1.9 billion from 26 venture firms. In mid-November 2026, London-based Oyster Therapeutics raised $60 million in a Series A round.
- Field
- medicine and diagnostics
- What they did
- Investors are once again actively funding startups developing drugs to treat brain diseases, despite the complexity of such research.
- Why it matters
- Between 2023 and 2025, companies in the neuroscience field received 1.09 billion, 1.58 billion, and 1.9 billion dollars from venture firms respectively.
#neuroscience#venture capital#startups#oyster therapeutics#funding
